| References |
|
|
Allen R,
Walters A,
Montplaisir J et al.
(2005)
Restless legs syndrome prevalence and impact: REST general population study.
Archives of Internal Medicine
165(11):
1286–1292.
|
|
|
Blouin AM,
Thannickal TC,
Worley PF et al.
(2005)
Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.
Neurology
65(8):
1189–1192.
|
|
|
Bonati MT,
Ferini-Strambi L,
Aridon P et al.
(2003)
Autosomal dominant restless legs syndrome maps on chromosome 14q.
Brain
126(Pt 6):
1485–1492.
|
|
|
Boström KB,
Hedner J,
Melander O et al.
(2007)
Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension.
Journal of Hypertension
25(4):
779–783.
|
|
|
Caylak E
(2009)
The genetics of sleep disorders in humans: narcolepsy, restless legs syndrome, and obstructive sleep apnea syndrome.
American Journal of Medical Genetics Part A
149A(11):
2612–2626.
|
|
|
Chen S,
Ondo WG,
Rao S et al.
(2004)
Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p.
American Journal of Medical Genetics
74(5):
876–885.
|
|
|
Dauvilliers Y,
Blouin JL,
Neidhart E et al.
(2004)
A narcolepsy susceptibility locus maps to a 5Mb region of chromosome 21q.
Annals of Neurology
56(3):
382–388.
|
|
|
Dauvilliers Y,
Maret S and
Tafti M
(2005)
Genetics of normal and pathological sleep in humans.
Sleep Medicine Reviews
9(2):
91–100.
|
|
|
Desautels A,
Turecki G,
Montplaisir J et al.
(2001)
Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q.
American Journal of Medical Genetics
69(6):
1266–1270.
|
|
|
Desautels A,
Turecki G,
Montplaisir J et al.
(2002)
Evidence for a genetic association between monoamine oxidase A and restless legs syndrome.
Neurology
59(2):
215–219.
|
|
|
Desautels A,
Turecki G,
Montplaisir J et al.
(2005)
Restless legs syndrome: confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity.
Archives of Neurology
62(4):
591–596.
|
|
|
Gencik M,
Dahmen N,
Wieczorek S et al.
(2001)
A prepro-orexin gene polymorphism is associated with narcolepsy.
Neurology
56(1):
115–117.
|
|
|
von Gontard A,
Eiberg H,
Hollmann E,
Rittig S and
Lehmkuhl G
(1988)
Molecular genetics of nocturnal enuresis: clinical and genetic heterogeneity.
Acta Paediatrica
87(5):
571–578.
|
|
|
Gottlieb DJ,
DeStefano AL,
Foley DJ et al.
(2004)
APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study.
Neurology
63(4):
664–668.
|
|
|
Gozal D,
Capdevila OS,
Kheirandish-Gozal L and
Crabtree VM
(2007)
APOE epsilon 4 allele, cognitive dysfunction, and obstructive sleep apnea in children.
Neurology
69(3):
243–249.
|
|
|
Hallmayer J,
Faraco J,
Lin L et al.
(2009)
Narcolepsy is strongly associated with the T-cell receptor alpha locus.
Nature Genetics
41(6):
708–711.
|
|
|
Hirayama J and
Sassone-Corsi P
(2005)
Structural and functional features of transcription factors controlling the circadian clock.
Current Opinion in Genetics & Development
15(5):
548–556.
|
|
|
Hohjoh H,
Takasu M,
Shishikura K et al.
(2003)
Significant association of the arylalkylamine N-acetyltransferase (AA-NAT) gene with delayed sleep phase syndrome.
Neurogenetics
4(3):
151–153.
|
|
|
Hor H,
Kutalik Z,
Dauvilliers Y et al.
(2010)
Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy.
Nature Genetics
42(9):
786–789.
|
|
|
Hublin C,
Kaprio J,
Partinen M,
Heikkila K and
Koskenvuo M
(1997)
Prevalence and genetics of sleepwalking: a population-based twin study.
Neurology
48(1):
177–181.
|
|
|
book
International Classification of Sleep Disorders, Version 2
(2005)
Diagnostic and Coding Manual.
Rochester, Minnesota: American Academy of Sleep Medicine.
|
|
|
Kadotani H,
Kadotani T,
Young T et al.
(2001)
Association between apolipoprotein E epsilon-4 and sleep-disordered breathing in adults.
Journal of American Medical Association
285(22):
2888–2890.
|
|
|
Kawashima M,
Tamiya G,
Oka A et al.
(2006)
Genomewide association analysis of human narcolepsy and a new resistance gene.
American Journal of Medical Genetics
79(2):
252–263.
|
|
|
Kemlink D,
Polo O,
Frauscher B et al.
(2009)
Replication of restless legs syndrome loci in three European populations.
Journal of Medical Genetics
46(5):
315–318.
|
|
|
Kemlink D,
Polo O,
Montagna P et al.
(2007)
Family based association study of the restless legs syndrome loci 2 and 3 in a European population.
Movement Disorders
22(2):
207–212.
|
|
|
Kock N,
Culjkovic B,
Maniak S et al.
(2002)
Mode of inheritance and susceptibility locus for restless legs syndrome, on chromosome 12q.
American Journal of Medical Genetics
71(1):
205–208.
|
|
|
Lam JC,
Sharma SK and
Lam B
(2010)
Obstructive sleep apnoea: definitions, epidemiology & natural history.
Indian Journal of Medical Research
131:
165–170.
|
|
|
Larkin EK,
Patel SR,
Redline S et al.
(2006)
Apolipoprotein E and obstructive sleep apnea: evaluating whether a candidate gene explains a linkage peak.
Genetic Epidemiology
30(2):
101–110.
|
|
|
Lavigne GJ and
Montplaisir JY
(1994)
Restless legs syndrome and sleep bruxism: prevalence and association among Canadians.
Sleep
17(8):
739–743.
|
|
|
Lecendreux M,
Bassetti C,
Dauvilliers Y et al.
(2003)
HLA and genetic susceptibility to sleepwalking.
Molecular Psychiatry
8(1):
114–117.
|
|
|
Levchenko A,
Montplaisir JY,
Dube MP et al.
(2004)
The 14q restless legs syndrome locus in the French Canadian population.
Annals of Neurology
55(6):
887–891.
|
|
|
Levchenko A,
Provost S,
Montplaisir JY et al.
(2006)
A novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13.
Neurology
67(5):
900–901.
|
|
|
Liebetanz KM,
Winkelmann J,
Trenkwalder C et al.
(2006)
RLS3: fine-mapping of an autosomal dominant locus in a family with intrafamilial heterogeneity.
Neurology
67(2):
320–321.
|
|
|
Loeys B,
Hoebeke P,
Raes A et al.
(2002)
Does monosymptomatic enuresis exist? A molecular genetic exploration of 32 families with enuresis/incontinence.
British Journal of Urology International
90(1):
76–83.
|
|
|
Lohmann-Hedrich K,
Neumann A,
Kleensang A et al.
(2008)
Evidence for linkage of restless legs syndrome to chromosome 9p: are there two distinct loci?
Neurology
70(9):
686–694.
|
|
|
Miyagawa T,
Kawashima M,
Nishida N et al.
(2008)
Variant between CPT1B and CHKB associated with susceptibility to narcolepsy.
Nature Genetics
40(11):
1324–1328.
|
|
|
Nakayama J,
Miura M,
Honda M et al.
(2000)
Linkage of human narcolepsy with HLA association to chromosome 4p13-q21.
Genomics
65(1):
84–86.
|
|
|
Nightingale S,
Orgill JC,
Ebrahim IO et al.
(2005)
The association between narcolepsy and REM behavior disorder (RBD).
Sleep Medicine
6(3):
253–258.
|
|
|
O'Hara R,
Schröder CM,
Kraemer HC et al.
(2005)
Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers.
Neurology
65(4):
642–644.
|
|
|
Ohayon MM,
Guilleminault C and
Priest RG
(1999)
Night terrors, sleepwalking, and confusional arousals in the general population: their frequency and relationship to other sleep and mental disorders.
Journal of Clinical Psychiatry
60(4):
268–276, quiz 277.
|
|
|
Palmer LJ,
Buxbaum SG,
Larkin EK et al.
(2004)
Whole genome scan for obstructive sleep apnea and obesity in African-American families.
American Journal of Respiratory and Critical Care Medicine
169(12):
1314–1321.
|
|
|
Patel S
(2002)
Restless legs syndrome and periodic limb movements of sleep: fact, fad, and fiction.
Current Opinion in Pulmonary Medicine
8(5):
498–501.
|
|
|
Pichler I,
Marroni F,
Volpato CB et al.
(2006)
Linkage analysis identifies a novel locus for restless legs syndrome on chromosome 2q in a South Tyrolean population isolate.
American Journal of Human Genetics
79(4):
716–723.
|
|
|
Schenck CH,
Garcia-Rill E,
Segall M,
Noreen H and
Mahowald MW
(1996)
HLA class II genes associated with REM sleep behavior disorder.
Annals of Neurology
39(2):
261–263.
|
|
|
Schrader H,
Bovim G and
Sand T
(1993)
The prevalence of delayed and advanced sleep phase syndromes.
Journal of Sleep Research
2(1):
51–55.
|
|
|
Shibui K,
Uchiyama M and
Okawa M
(1999)
Melatonin rhythms in delayed sleep phase syndrome.
Journal of Biological Rhythms
14(1):
72–76.
|
|
|
Staeheli P
(1990)
Interferon-induced proteins and the antiviral state.
Advances in Virus Research
38:
147–200.
|
|
|
Stefansson H,
Rye DB,
Hicks A et al.
(2007)
A genetic risk factor for periodic limb movements in sleep.
New England Journal of Medicine
357(7):
639–647.
|
|
|
Strollo PJ Jr and
Rogers RM
(1996)
Obstructive sleep apnea.
New England Journal of Medicine
334(2):
99–104.
|
|
|
Taheri S and
Mignot E
(2002)
The genetics of sleep disorders.
Lancet Neurology
1(4):
242–250.
|
|
|
Tanaka S,
Honda Y and
Honda M
(2007)
Identification of differentially expressed genes in blood cells of narcolepsy patients.
Sleep
30(8):
974–979.
|
|
|
Toh KL,
Jones CR,
He Y et al.
(2001)
An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome.
Science
291(5506):
1040–1043.
|
|
|
Vilarino-Guell C,
Farrer MJ and
Lin SC
(2008)
A genetic risk factor for periodic limb movements in sleep.
New England Journal of Medicine
358(4):
425–427.
|
|
|
Winkelmann J,
Lichtner P,
Pütz B et al.
(2006)
Evidence for further genetic locus heterogeneity and confirmation of RLS-1 in restless legs syndrome.
Movement Disorders
21(1):
28–33.
|
|
|
Winkelmann J,
Schormair B,
Lichtner P et al.
(2007)
Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions.
Nature Genetics
39(8):
1000–1006.
|
|
|
Xiong L,
Dion P,
Montplaisir J et al.
(2007)
Molecular genetic studies of DMT1 on 12q in French-Canadian restless legs syndrome patients and families.
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
144B(7):
911–917.
|
|
|
Xu Y,
Padiath QS,
Shapiro RE et al.
(2005)
Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome.
Nature
434(7033):
640–644.
|
|
|
Zhang J,
Zhao B,
Gesongluobu SY et al.
(2000)
Angiotensin-converting enzyme gene insertion/deletion (I/D) polymorphism in hypertensive patients with different degrees of obstructive sleep apnea.
Hypertension Research
23(5):
407–411.
|
| Further Reading |
|
|
book
Carskadon MA and
Dement WC
(2000)
"Normal human sleep: an overview".
In: Kryger MH,
Roth T and
Dement WC (eds)
Principles and Practice of Sleep Medicine,
pp. 15–25.
Philadelphia: Saunders.
|
|
|
book
Carskadon MA and
Rechtschaffen A
(2000)
"Monitoring and staging human sleep".
In: Kryger MH,
Roth T and
Dement WC (eds)
Principles and Practice of Sleep Medicine,
pp. 1197–1215.
Philadelphia: Saunders.
|
|
|
book
Kelsey JE,
Nemeroff CB and
Newport DJ
(2006)
Principles of Psychopharmacology for Mental Health Professionals.
New Jersey: John Wiley & Sons.
|
|
|
book
Lee-Chiong T (ed.)
(2005)
Frontmatter, in Sleep: A Comprehensive Handbook.
New Jersey: John Wiley & Sons.
|
|
|
Mignot E
(2004)
Sleep, sleep disorders and hypocretin (orexin).
Sleep Medicine
5(suppl. 1):
S2–S8.
|
|
|
Partinen M,
Kaprio J,
Koskenvuo M,
Putkonen P and
Langinvainio H
(1983)
Genetic and environmental determination of human sleep.
Sleep
6(3):
179–185.
|
|
|
Raizen DM and
Wu MN
(2011)
Genome-wide association studies of sleep disorders.
Chest
139(2):
446–452.
|
